Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIRS NASDAQ:AVAH NASDAQ:GRAL NASDAQ:PGNY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIRSAirSculpt Technologies$8.22+0.5%$6.56$1.53▼$9.20$514.63M2.53527,724 shs7,836 shsAVAHAveanna Healthcare$8.56+0.5%$7.36$3.67▼$9.03$1.79B2.05677,190 shs10,801 shsGRALGRAIL$62.85+1.9%$39.16$12.57▼$73.74$2.28B4.111.27 million shs35,941 shsPGNYProgyny$19.81-1.9%$22.53$13.39▼$26.76$1.70B1.341.35 million shs10,943 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIRSAirSculpt Technologies+5.68%+8.49%+39.12%+52.33%+65.25%AVAHAveanna Healthcare-1.39%-4.06%+3.53%+98.83%+87.86%GRALGRAIL-5.86%+4.99%+67.16%+44.02%+373.52%PGNYProgyny-1.94%-5.74%-10.47%-16.81%+23.87%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIRSAirSculpt Technologies$8.22+0.5%$6.56$1.53▼$9.20$514.63M2.53527,724 shs7,836 shsAVAHAveanna Healthcare$8.56+0.5%$7.36$3.67▼$9.03$1.79B2.05677,190 shs10,801 shsGRALGRAIL$62.85+1.9%$39.16$12.57▼$73.74$2.28B4.111.27 million shs35,941 shsPGNYProgyny$19.81-1.9%$22.53$13.39▼$26.76$1.70B1.341.35 million shs10,943 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIRSAirSculpt Technologies+5.68%+8.49%+39.12%+52.33%+65.25%AVAHAveanna Healthcare-1.39%-4.06%+3.53%+98.83%+87.86%GRALGRAIL-5.86%+4.99%+67.16%+44.02%+373.52%PGNYProgyny-1.94%-5.74%-10.47%-16.81%+23.87%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIRSAirSculpt Technologies 1.75Reduce$3.75-54.38% DownsideAVAHAveanna Healthcare 2.43Hold$7.92-7.46% DownsideGRALGRAIL 2.00Hold$56.67-9.83% DownsidePGNYProgyny 2.70Moderate Buy$25.4428.45% UpsideCurrent Analyst Ratings BreakdownLatest AIRS, PGNY, AVAH, and GRAL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/3/2025GRALGRAILUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$75.0010/3/2025GRALGRAILCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$43.00 ➝ $75.009/27/2025AIRSAirSculpt TechnologiesWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025AVAHAveanna HealthcareWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)9/27/2025GRALGRAILWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025PGNYProgynyWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C-)9/18/2025AVAHAveanna HealthcareJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeUnderweight ➝ Neutral$6.00 ➝ $10.008/26/2025PGNYProgynyJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$23.00 ➝ $25.008/20/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetHold$21.00 ➝ $23.008/19/2025AVAHAveanna HealthcareBarclaysSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeEqual Weight ➝ Overweight$5.50 ➝ $9.508/19/2025AVAHAveanna HealthcareUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell ➝ Neutral$6.75 ➝ $8.00(Data available from 10/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIRSAirSculpt Technologies$180.35M2.85$0.18 per share46.15$1.37 per share6.00AVAHAveanna Healthcare$2.02B0.88$0.16 per share52.63($0.64) per share-13.37GRALGRAIL$125.60M18.04$27.69 per share2.27$74.50 per share0.84PGNYProgyny$1.24B1.37$0.33 per share59.67$4.96 per share3.99Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIRSAirSculpt Technologies-$8.25M-$0.25N/A∞N/A-8.79%-15.63%-6.30%11/14/2025 (Estimated)AVAHAveanna Healthcare-$10.93M$0.08107.23∞N/A0.85%-54.56%3.17%11/6/2025 (Estimated)GRALGRAIL-$2.03B-$13.11N/AN/AN/A-329.86%-16.64%-14.02%11/11/2025 (Estimated)PGNYProgyny$54.34M$0.5933.5530.481.754.28%10.69%7.12%11/11/2025 (Estimated)Latest AIRS, PGNY, AVAH, and GRAL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025GRALGRAIL-$3.14-$3.18-$0.04-$3.18$37.57 million$35.54 million8/7/2025Q2 2025PGNYProgyny$0.42$0.19-$0.23$0.19$315.70 million$332.87 million8/1/2025Q2 2025AIRSAirSculpt Technologies$0.02$0.02N/A-$0.01$45.59 million$44.01 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIRSAirSculpt TechnologiesN/AN/AN/AN/AN/AAVAHAveanna HealthcareN/AN/AN/AN/AN/AGRALGRAILN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAIRSAirSculpt Technologies0.580.640.64AVAHAveanna HealthcareN/A1.091.09GRALGRAILN/A9.239.23PGNYProgynyN/A2.702.70Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIRSAirSculpt Technologies91.54%AVAHAveanna Healthcare87.96%GRALGRAILN/APGNYProgyny94.93%Insider OwnershipCompanyInsider OwnershipAIRSAirSculpt Technologies76.58%AVAHAveanna Healthcare7.00%GRALGRAILN/APGNYProgyny9.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIRSAirSculpt Technologies24062.44 million14.62 millionOptionableAVAHAveanna Healthcare33,500208.90 million194.27 millionOptionableGRALGRAIL1,36036.05 millionN/AOptionablePGNYProgyny31085.98 million77.90 millionOptionableAIRS, PGNY, AVAH, and GRAL HeadlinesRecent News About These CompaniesProgyny, Inc. CEO Pete Anevski Recognized as Champion for Women’s Health by World Economic Forum1 hour ago | quiverquant.comQProgyny CEO Named World Economic Forum Champion for Women's Health1 hour ago | globenewswire.comProgyny, Inc. (NASDAQ:PGNY) Given Consensus Recommendation of "Moderate Buy" by BrokeragesOctober 6 at 2:37 AM | marketbeat.comProgyny (NASDAQ:PGNY) Trading Down 5.2% - What's Next?October 2, 2025 | marketbeat.com3 Reasons to Avoid PGNY and 1 Stock to Buy InsteadOctober 2, 2025 | finance.yahoo.comGC Wealth Management RIA LLC Acquires Shares of 29,429 Progyny, Inc. $PGNYOctober 1, 2025 | marketbeat.comFort Washington Investment Advisors Inc. OH Decreases Stake in Progyny, Inc. $PGNYSeptember 29, 2025 | marketbeat.comProgyny (NASDAQ:PGNY) Is Doing The Right Things To Multiply Its Share PriceSeptember 25, 2025 | finance.yahoo.comVoya Investment Management LLC Acquires 133,703 Shares of Progyny, Inc. $PGNYSeptember 20, 2025 | marketbeat.comHealth Insurance Providers Stocks Q2 Results: Benchmarking Progyny (NASDAQ:PGNY)September 16, 2025 | finance.yahoo.comAcadian Asset Management LLC Acquires 145,802 Shares of Progyny, Inc. $PGNYSeptember 16, 2025 | marketbeat.comCaxton Associates LLP Takes $555,000 Position in Progyny, Inc. $PGNYSeptember 14, 2025 | marketbeat.comMillennium Management LLC Acquires 90,367 Shares of Progyny, Inc. $PGNYSeptember 14, 2025 | marketbeat.comAQR Capital Management LLC Increases Stake in Progyny, Inc. $PGNYSeptember 14, 2025 | marketbeat.comBayforest Capital Ltd Invests $344,000 in Progyny, Inc. $PGNYSeptember 13, 2025 | marketbeat.comProgyny, Inc. (NASDAQ:PGNY) Receives Average Recommendation of "Moderate Buy" from BrokeragesSeptember 13, 2025 | marketbeat.comSciencast Management LP Takes $711,000 Position in Progyny, Inc. $PGNYSeptember 11, 2025 | marketbeat.comQ2 Earnings Highs And Lows: McKesson (NYSE:MCK) Vs The Rest Of The Healthcare Providers & Services StocksSeptember 11, 2025 | msn.comFred Alger Management LLC Has $28.29 Million Holdings in Progyny, Inc. $PGNYSeptember 10, 2025 | marketbeat.comCubist Systematic Strategies LLC Has $1.02 Million Position in Progyny, Inc. $PGNYSeptember 10, 2025 | marketbeat.comProgyny's Strong Fundamentals & Global Growth: Why I Choose To BUYSeptember 9, 2025 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025The Fed Cut Rates: What Now for the S&P 500 and Equity Markets?By Thomas Hughes | September 18, 2025Why Datavault May Be the Penny AI Stock Investors Have Waited ForBy Nathan Reiff | September 22, 20253 Hot Tech Stocks With Bullish Charts and Ample UpsideBy Thomas Hughes | September 15, 2025After the Fed's Rate Cut, PNC Could See a Mortgage Refinance BoomBy Jordan Chussler | September 21, 2025AIRS, PGNY, AVAH, and GRAL Company DescriptionsAirSculpt Technologies NASDAQ:AIRS$8.22 +0.04 (+0.54%) As of 09:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure. It also provides AirSculpt+, a procedure that permanently removes fat and tightens the skin with unparalleled precision and finesse; and AirSculpt Smooth, an advanced cellulite removal tool. In addition, it provides fat removal procedures across treatment areas, such as the stomach, back, and buttocks; and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips, or other areas. The company's body contouring procedures also include the Power BBL, a Brazilian butt lift procedure; the Up a Cup, a breast enhancement procedure; and the Hip Flip, an hourglass contouring procedure. It operates various centers. The company was founded in 2012 and is headquartered in Miami Beach, Florida.Aveanna Healthcare NASDAQ:AVAH$8.56 +0.05 (+0.53%) As of 09:54 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.GRAIL NASDAQ:GRAL$62.82 +1.12 (+1.81%) As of 09:54 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.Progyny NASDAQ:PGNY$19.81 -0.38 (-1.88%) As of 09:54 AM Eastern This is a fair market value price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Marvell Insiders Buy Shares—Should Investors Follow Suit? TrumpRx Brings Pfizer Into the Green—Is It a Buy? Behind D-Wave's Massive Week (And Why Rivals Also Popped) Eli Lilly Stock Soars on Trump Tariff Hopes and Pfizer Deal Cheap Chipotle? Why CMG Stock Could Be Ready for a Comeback Alphabet: After Its Best Quarter in Decades, Is It Time to Buy? Best Stocks Under $15? 3 Low-Priced Picks With Upside After Trump Deal, Can Meta Stock Withstand TikTok’s Onslaught? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
